Clinical Characteristics, Surgical Management, and Outcomes of Borderline Ovarian Tumours: A Retrospective Observational Study from North East London †
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Clinical Features
3.2. CA-125 Levels
3.3. Imaging Findings
3.4. Surgical Management
3.5. Follow-Up
3.6. Miscellaneous Findings
4. Discussion
Strengths and Limitations of the Study
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Kipp, B.; Vidal, A.; Lenick, D.; Christmann-Schmid, C. Management of Borderline ovarian tumors (BOT): Results of a retrospective, single center study in Switzerland. J. Ovarian Res. 2023, 16, 1–6. [Google Scholar] [CrossRef]
- Riman, T.; Dickman, P.W.; Nilsson, S.; Correia, N.; Nordlinder, H.; Magnusson, C.M.; Persson, I.R. Risk Factors for Epithelial Borderline Ovarian Tumors: Results of a Swedish Case–Control Study. Gynecol. Oncol. 2001, 83, 575–585. [Google Scholar] [CrossRef] [PubMed]
- Zheng, G.; Yu, H.; Kanerva, A.; Försti, A.; Sundquist, K.; Hemminki, K. Borderline Ovarian Tumors Share Familial Risks with Themselves and Invasive Cancers. Cancer Epidemiol. Biomark. Prev. 2018, 27, 1358–1363. [Google Scholar] [CrossRef] [PubMed]
- Vancraeynest, E.; Moerman, P.; Leunen, K.; Amant, F.; Neven, P.; Vergote, I. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors. Int. J. Gynecol. Cancer 2016, 26, 1399–1406. [Google Scholar] [CrossRef] [PubMed]
- Hart, W.R. Mucinous tumors of the ovary: A review. Int. J. Gynecol. Pathol. 2005, 24, 4–25. [Google Scholar]
- Barnhill, D.R.; Kurman, R.J.; Brady, M.F.; A Omura, G.; Yordan, E.; Given, F.T.; Kucera, P.R.; Roman, L.D. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: A Gynecologic Oncology Group study. J. Clin. Oncol. 1995, 13, 2752–2756. [Google Scholar] [CrossRef]
- Meinhold-Heerlein, I.; Fotopoulou, C.; Harter, P.; Kurzeder, C.; Mustea, A.; Wimberger, P.; Hauptmann, S.; Sehouli, J.; Ago, F.T.K.O.O.T. Statement by the Kommission Ovar of the AGO: The New FIGO and WHO Classifications of Ovarian, Fallopian Tube and Primary Peritoneal Cancer. Geburtshilfe Und Frauenheilkd. 2015, 75, 1021–1027. [Google Scholar] [CrossRef]
- Prat, J.; FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int. J. Gynecol. Obstet. 2013, 124, 1–5. [Google Scholar] [CrossRef]
- Koensgen, D.; Weiss, M.; Assmann, K.; Brucker, S.Y.; Wallwiener, D.; Stope, M.B.; Mustea, A. Characterization and Management of Borderline Ovarian Tumors—Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine Greifswald. Anticancer Res. 2018, 38, 1539–1545. [Google Scholar] [CrossRef]
- May, J.; Skorupskaite, K.; Congiu, M.; Ghaoui, N.; Walker, G.A.; Fegan, S.; Martin, C.W.; O’donnell, R.L. Borderline Ovarian Tumors. Int. J. Gynecol. Cancer 2018, 28, 1683–1691. [Google Scholar] [CrossRef]
- Lalwani, N.; Shanbhogue, A.K.P.; Vikram, R.; Nagar, A.; Jagirdar, J.; Prasad, S.R. Current Update on Borderline Ovarian Neoplasms. Am. J. Roentgenol. 2010, 194, 330–336. [Google Scholar] [CrossRef]
- Trillsch, F.; Mahner, S.; Ruetzel, J.; Harter, P.; Ewald-Riegler, N.; Jaenicke, F.; du Bois, A. Clinical management of borderline ovarian tumors. Expert Rev. Anticancer Ther. 2010, 10, 1115–1124. [Google Scholar] [CrossRef] [PubMed]
- Ren, J.; Peng, Z.; Yang, K. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors. Gynecol. Oncol. 2008, 110, 162–167. [Google Scholar] [CrossRef] [PubMed]
- Pirimoglu, Z.M.; Afsin, Y.; Guzelmeric, K.; Yilmaz, M.; Unal, O.; Turan, M.C. Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors? Arch. Gynecol. Obstet. 2007, 277, 411–414. [Google Scholar] [CrossRef]
- Ji, H.; Yliskoski, M.; Anttila, M.; Syrjänen, K.; Saarikoski, S. Management of stage-I borderline ovarian tumors. Int. J. Gynecol. Obstet. 1996, 54, 37–44. [Google Scholar] [CrossRef]
- Desfeux, P.; Camatte, S.; Chatellier, G.; Blanc, B.; Querleu, D.; Lécuru, F. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gynecol. Oncol. 2005, 98, 390–395. [Google Scholar] [CrossRef]
- Wong, H.; Low, J.; Chua, Y.; Busmanis, I.; Tay, E.; Ho, T. Ovarian tumors of borderline malignancy: A review of 247 patients from 1991 to 2004. Int. J. Gynecol. Cancer 2007, 17, 342–349. [Google Scholar] [CrossRef]
- Ayhan, A.; Guven, S.; Guven, E.S.G.; Kucukali, T. Is There a Correlation Between Tumor Marker Panel and Tumor Size and Histo-pathology in Well-Staged Patients with Borderline Ovarian Tumors? Acta Obstet. Gynecol. Scand. 2007, 86, 484–490. [Google Scholar]
- Hauptmann, S.; Friedrich, K.; Redline, R.; Avril, S. Ovarian borderline tumors in the 2014 WHO classification: Evolving concepts and diagnostic criteria. Virchows Arch. 2016, 470, 125–142. [Google Scholar] [CrossRef]
- Yüksel, D.; Çakır, C.; Cömert, G.K.; Kılıç, Ç.; Durmuş, Y.; Boran, N.; Boyraz, G.; Karalök, A.; Turan, T. Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients. J. Turk. Gynecol. Assoc. 2019, 20, 224–230. [Google Scholar] [CrossRef]
- Jia, S.-Z.; Zhang, J.-J.; Liang, Z.-Y.; Yang, J.-J.; Xiang, Y.; Jia, C.-W.; Leng, J.-H. Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours. BMC Cancer 2018, 18, 1160. [Google Scholar] [CrossRef] [PubMed]
- Romagnolo, C.; Gadducci, A.; Sartori, E.; Zola, P.; Maggino, T. Management of borderline ovarian tumors: Results of an Italian multicenter study. Gynecol. Oncol. 2006, 101, 255–260. [Google Scholar] [CrossRef] [PubMed]
- Rice, L.W.; Lage, J.M.; Berkowitz, R.S.; Goodman, A.; Muto, M.G.; Knapp, R.C.; Bell, D.A. Preoperative serum CA-125 levels in borderline tumors of the ovary. Gynecol. Oncol. 1992, 46, 226–229. [Google Scholar] [CrossRef]
- Verta, S.; Kipp, B. Ultraconservative, Fertility-Sparing Treatment of Bilateral Borderline Ovarian Tumors: A Case Report and Review of the Literature. Int. J. Womens Health 2020, 12, 601–611. [Google Scholar] [CrossRef]
- Morris, R. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet. Gynecol. 2000, 95, 541–547. [Google Scholar] [CrossRef]
- Hogg, R.; Scurry, J.; Kim, S.-N.; Friedlander, M.; Hacker, N. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma. Gynecol. Oncol. 2007, 106, 44–51. [Google Scholar] [CrossRef]
- Shih, K.; Zhou, Q.; Huh, J.; Morgan, J.; Iasonos, A.; Aghajanian, C.; Chi, D.; Barakat, R.; Abu-Rustum, N. Risk factors for recurrence of ovarian borderline tumors. Gynecol. Oncol. 2011, 120, 480–484. [Google Scholar] [CrossRef] [PubMed]
- du Bois, A.; Ewald-Riegler, N.; de Gregorio, N.; Reuss, A.; Mahner, S.; Fotopoulou, C.; Kommoss, F.; Schmalfeldt, B.; Hilpert, F.; Fehm, T.; et al. Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group. Eur. J. Cancer 2013, 49, 1905–1914. [Google Scholar] [CrossRef]
- Gungor, T.; Cetinkaya, N.; Yalcin, H.; Ozdal, B.; Ozgu, E.; Baser, E.; Uygur, D.; Caglar, M.; Sirvan, L.; Erkaya, S. Retrospective evaluation of borderline ovarian tumors: Single center experience of 183 cases. Arch. Gynecol. Obstet. 2014, 291, 123–130. [Google Scholar] [CrossRef]
- Young, R. Monodermal teratomas and somatic-type tumours arising from a dermoid cyst. In WHO Classification of Tumours of the Female Reproductive Organs, 4th ed.; Kurman, R.J., Carcangiu, M.L., Herrington, C.S., Young, R.H., Eds.; World Health Organisation: Lyon, France, 2014; pp. 63–66. [Google Scholar]
- Wagner, U.; Reus, A. S3-Leitlinie “Diagnostik, Therapie und Nachsorge Maligner Ovarialtumore”: Langversion 3.0, 2019; AWMF-Registernummer: 032/035OL; AWMF: Palmerston, NT, USA, 2019; pp. 413–415. [Google Scholar]
- Alvarez, R.M. Fertility sparing treatment in borderline ovarian tumours. Ecancermedicalscience 2015, 9, 507. [Google Scholar] [CrossRef]
- Song, T.; Choi, C.H.; Lee, Y.-Y.; Kim, T.-J.; Lee, J.-W.; Bae, D.-S.; Kim, B.-G. Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours. Hum. Reprod. 2011, 26, 2008–2014. [Google Scholar] [CrossRef] [PubMed]
- Trope, C.G.; Kaern, J.; Davidson, B. Borderline Ovarian Tumors. Best Pract. Res. Clin. Obstet. Gynaecol. 2012, 26, 325–336. [Google Scholar]
- Fauvet, R.; Boccara, J.; Dufournet, C.; Poncelet, C.; Daraï, E. Laparoscopic management of borderline ovarian tumors: Results of a French multicenter study. Ann. Oncol. 2005, 16, 403–410. [Google Scholar] [CrossRef] [PubMed]
- Lenhard, M.S.; Mitterer, S.; Kümper, C.; Stieber, P.; Mayr, D.; Ditsch, N.; Friese, K.; Burges, A. Long-term follow-up after ovarian borderline tumor: Relapse and survival in a large patient cohort. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009, 145, 189–194. [Google Scholar] [CrossRef]
- Ozenne, A.; De Berti, M.; Body, G.; Carcopino, X.; Graesslin, O.; Kerbage, Y.; Akladios, C.; Huchon, C.; Bricou, A.; Mimoun, C.; et al. Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group. J. Clin. Med. 2022, 11, 3645. [Google Scholar] [CrossRef]
- Suh-Burgmann, E. Long-term outcomes following conservative surgery for borderline tumor of the ovary: A large population-based study. Gynecol. Oncol. 2006, 103, 841–847. [Google Scholar] [CrossRef]
- Gaughran, J.; O’sullivan, H.R.; Lyne, T.; Abdelbar, A.; Abdalla, M.; Sayasneh, A. Fertility Preserving Surgery Outcomes for Ovarian Malignancy: Data from a Tertiary Cancer Centre in Central London. J. Clin. Med. 2022, 11, 3195. [Google Scholar] [CrossRef]
- Tinelli, F.; Tinelli, R.; La Grotta, F.; Tinelli, A.; Cicinelli, E.; Schönauer, M. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors. Acta Obstet. Gynecol. Scand. 2007, 86, 81–87. [Google Scholar] [CrossRef] [PubMed]
- Trillsch, F.; Mahner, S.; Vettorazzi, E.; Woelber, L.; Reuss, A.; Baumann, K.; Keyver-Paik, M.-D.; Canzler, U.; Wollschlaeger, K.; Forner, D.; et al. Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study. Br. J. Cancer 2015, 112, 660–666. [Google Scholar] [CrossRef]
- Camatte, S.; Morice, P.; Thoury, A.; Fourchotte, V.; Pautier, P.; Lhomme, C.; Duvillard, P.; Castaigne, D. Impact of Surgical Staging in Patients with Macroscopic “Stage I” Ovarian Borderline Tumors. Eur. J. Cancer 2004, 40, 1842–1849. [Google Scholar]
- McKenney, J.K.; Balzer, B.L.; Longacre, T.A. Lymph Node Involvement in Ovarian Serous Tumors of Low Malignant Potential: Pathology, Prognosis, and Proposed Classification. Am. J. Surg. Pathol. 2006, 30, 614–624. [Google Scholar] [PubMed]
- Hashi, A.; Jamdade, K.; Deo, N. Audit of borderline ovarian tumours at Barts Health NHS Trust. Presented at National Trainees Conference, Brighton, UK, 20–21 May 2024. [Google Scholar]
Characteristics | N = 69 |
Age | 44 |
Median age (range) | 20–77 |
Age groups (n (%)) | |
<40 years | 32 (46.37%) |
≥40 years | 37 (53.62%) |
Parity (n (%)) | |
Nulliparous | 35 (50.72%) |
Parous | 34 (49.27%) |
Body mass index (kg/m2) | |
Median BMI (range) | 25.5 (18–39) |
BMI groups (n (%)) | |
Underweight (<18) | 2 (2.89%) |
Normal (18–24.9) | 27 (39.13%) |
Overweight (25–29.9) | 19 (27.53%) |
Obesity (>30) | 21 (30.43%) |
Tumour Characteristics | Tumour Sub-Types | |||||
---|---|---|---|---|---|---|
Serous N = 19 (27.53%) | Mucinous N = 39 (56.52%) | Sero-Mucinous N = 7 (10.14%) | Mucino-Intestinal N = 2 (2.89%) | Other N = 2 (2.89%) | ||
FIGO | I | 13 (68.42) | 39 (100%) | 7 (100%) | 2 (100%) | 2 (100%) |
II | 3 (15.78%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
III | 2 (10.52% | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
IV | 1 (5.26%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
Location | Unilateral | 16 (84.21%) | 39 (100%) | 6 (85.71%) | 2 (100%) | 2 (100%) |
Bilateral | 3 (15.78%) | 0 (0.0%) | 1 (14.28%) | 0 (0.0%) | 0 (0.0%) | |
CA-125 | <35 | 7 (36.84%) | 15 (38.46%) | 5 (71.42%) | 0 (0.0%) | 1 (50.0%) |
>35 | 11 (57.89%) | 23 (58.97%) | 1 (14.28%) | 2 (100%) | 1 (50.0%) | |
Missing | 1 (5.26%) | 1 (2.56%) | 1 (14.28%) | 0 (0.0%) | 0 (0.0%) | |
Microinvasion | 2 (10.52%) | NA | NA | NA | NA | |
Focal intraepithelial Carcinoma | NA | 1 (2.56%) | NA | NA | NA |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Jamdade, K.; Hashi, A.; Deo, N. Clinical Characteristics, Surgical Management, and Outcomes of Borderline Ovarian Tumours: A Retrospective Observational Study from North East London. J. Clin. Med. 2025, 14, 2383. https://doi.org/10.3390/jcm14072383
Jamdade K, Hashi A, Deo N. Clinical Characteristics, Surgical Management, and Outcomes of Borderline Ovarian Tumours: A Retrospective Observational Study from North East London. Journal of Clinical Medicine. 2025; 14(7):2383. https://doi.org/10.3390/jcm14072383
Chicago/Turabian StyleJamdade, Kshitij, Amal Hashi, and Nandita Deo. 2025. "Clinical Characteristics, Surgical Management, and Outcomes of Borderline Ovarian Tumours: A Retrospective Observational Study from North East London" Journal of Clinical Medicine 14, no. 7: 2383. https://doi.org/10.3390/jcm14072383
APA StyleJamdade, K., Hashi, A., & Deo, N. (2025). Clinical Characteristics, Surgical Management, and Outcomes of Borderline Ovarian Tumours: A Retrospective Observational Study from North East London. Journal of Clinical Medicine, 14(7), 2383. https://doi.org/10.3390/jcm14072383